Anthem Biosciences Ltd.

We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization(“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. We are one ofthe few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilitiesacross drug discovery, development, and commercial manufacturing, according to the F&S Report. As a one-stop serviceprovider, we serve a range of customers, encompassing innovator-focused emerging biotech and large pharmaceuticalcompanies globally. We are one of the youngest Indian CRDMO companies and the fastest Indian CRDMO to achieve amilestone of ?10,000 million of revenue within 14 years of operations, reaching this milestone in Fiscal 2021, according to theF&S Report. We also recorded the highest revenue growth in Fiscal 2023 to Fiscal 2024 as compared to our peers in India andglobally, according to the F&S Report.